Skip to search formSkip to main contentSkip to account menu

Enduracin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Niacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
[Metabolic syndrome of insulin resistance: basic conception and consequences ( a review)].
2004
2004
[Exercise and nicotinic acid delayed action drug Enduracin: application in outpatient rehabilitation of patients with ischemic heart disease].
AIM To evaluate efficacy of combined use of moderate exercise and nicotinic acid drug enduracin in patients with coronary heart… 
2004
2004
[Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
It is well known now that hypolipidemic therapy is able to inhibit development of atherosclerosis. This decreases the rate of… 
1999
1999
[Lipid and non-lipid effects of enduracin in patients with arterial hypertension].
AIM To analyze lipid and non-lipid effects of 6-month administration of enduracine in patients with marked dislipoproteinemia… 
1999
1999
[Lipid and non-lipid effects of enduracin in patients with arterial hypertension].
1997
1997
[The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
13 patients aged 39 to 60 years with coronary atherosclerosis confirmed at selective coronary angiography combined with primary… 
1997
1997
[The effect of long-term Enduracin monotherapy on the clinical and biochemical status of patients with ischemic heart disease].
13 patients aged 39 to 60 years with coronary atherosclerosis confirmed at selective coronary angiography combined with primary… 
1997
1997
[Effects of enduracin on the level of cholesterol in flying personnel].
1996
1996
[Effect of enduracin on the activity of a cholesterol ester transfer protein in blood plasma of people with hypercholesteremia].
1993
1993
[The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting atherogenic dyslipidemias].
The hypolipidemic effects of induracin, a new long-acting nicotinic acid dosage form based on the waxy matrix, and its tolerance… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)